Cross-Sector Panel of Experts Offers Trusted Guidance and Answers New Yorkers’ Questions on the Importance of Older Adult New Yorkers Getting Vaccinated Against Covid-19

Widespread vaccination among adults will change the course of aging for all of New York City

New York, NEW YORK (January 21, 2021) – The New York City Department for the Aging, the Age-friendly NYC Commission, and the Global Coalition on Aging (GCOA), the world’s leading business voice on aging, collaborated yesterday on a webinar to help build trust and acceptance of the Covid-19 vaccines for New York’s older adults. The webinar, Science, Older New Yorkers, and Covid-19 Vaccination: A Virtual Forum Advancing Trust and Confidence for Older New Yorkers, aimed to increase the share of all New Yorkers vaccinated against Covid-19, with a special focus on the health and wellbeing of older adults. A second webinar, on February 9, from 2:30pm-4pm, will focus on community organizations working with older adults across the city.

“We are here to spread the word: the vaccine is safe, free, and available for older New Yorkers,” said Lorraine Cortés-Vázquez, Commissioner of the NYC Department for the Aging. “We brought together an impressive group of panelists to engage older adults, build trust within our communities, and help get older adults vaccinated.”

“The Covid-19 vaccines are safe and effective, and we need all New Yorkers to do the right thing to protect their friends and family, which is to get the vaccine once eligible,” said Health Commissioner Dr. Dave A. Chokshi. “Each of us knows and has worried about an aging parent, grandparent, or other relative during this pandemic. We must do everything that we can for our families, but also our city.”

The webinar was led by Commissioner Cortés-Vázquez and moderated by Michael Hodin, CEO of the Global Coalition on Aging. The expert panel included Dr. Susan Beane, Executive Medical Director, Healthfirst, and a member of the Age-friendly NYC Commission; Dr. Wafaa El-Sadr, Founder and Director, ICAP, and University Professor and Dr. Mathilde Krim-amfAR Chair of Global Health, Columbia University Mailman’s School of Public Health; Dr. Jennifer Rosen, Director, Epidemiology and Surveillance, NYC Department of Health and Mental Hygiene; and Dr. John Beard, Former Director, Ageing and Life Course at the World Health Organization (WHO), and Professor, University of New South Wales, Australia, and Chair of Global Coalition on Aging Advisory Council.

Age-friendly NYC has been a leader in healthier and more active aging since its founding, ten years ago. Now, in 2021, the Age-friendly City movement takes on an even more important role as the United Nations (UN) and the WHO declare 2021-2030 to be the Decade of Healthy Ageing.

“We had always looked at the Decade as an important platform for progress on transforming our 21st century miracle of longevity to one filled with healthier, fulfilled, and happier lives,” said Michael Hodin, CEO of the Global Coalition on Aging. “Encouraging older adults to make sure they are fully vaccinated against preventable diseases – such as shingles, flu, pneumococcal pneumonia – is built into the fabric and spirit of the Decade’s goals,” Hodin explained. “But now, with Covid-19, we are pleased to partner with the City and the Age-friendly NYC Commission to encourage all of us, including older New Yorkers, to get vaccinated. The Covid-19 vaccines protect our health, our parents’ health, and is critical for reopening NYC and getting back to the vibrancy, fun, and excitement of the greatest city on the planet. And with the UN here in NYC, our collaboration for the Decade takes on greater significance during a global pandemic that has placed older New Yorkers at greatest risk.” Hodin also pointed out the new Alliance To Beat Covid-19 | A Global Outreach & Awareness Campaign to Get Everyone Vaccinated as an important resource on the trust and confidence, especially for older adults, to get vaccinated.

“The partnership among the NYC Age-friendly Commission, the New York City Department for the Aging, and the Global Coalition on Aging is built on a multi-sector, New York-wide constituency,” said Kevin Crain, Chair of the Commission, and a senior executive at Bank of America. “The Commission looks forward to joining all New Yorkers in this next critical phase of the pandemic – getting everyone vaccinated and allowing aging New Yorkers to reemerge as a vital part of New York City’s economic, social, and community life.”

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.